Maddie Guy launches Buddy, a 10-in-1 dog supplement, in New York

Maddie Guy introduced Buddy, a premium dog supplement formulated with 23 active natural ingredients to target 10 health benefits, at a New York launch on December 19, 2024.

Rudder, a medium-sized short-coated brown dog, sits beside a packet labeled Buddy in a sunlit living room.

Maddie Guy, a dog wellness advocate with a sizable social following, launched Buddy, a premium dog supplement, with a press release distributed on Dec. 18, 2024, via Business Wire. The product was unveiled as a 10-in-1 daily meal topper containing 23 active, high-quality natural ingredients, positioned to address multiple aspects of canine health in a single, convenient offering. Additional coverage of this same incident.

The announcement, distributed via Business Wire and picked up in wider coverage including Grit Daily, framed Buddy as the public introduction of Guy’s brand and first product. Company materials stressed formulation and positioning rather than pricing or distribution specifics, describing the product as a science-forward option designed for everyday use at feeding time.

Buddy’s formula is described in the launch as targeting 10 distinct benefits, with the release explicitly citing joint support, digestion, heart health and coat vitality among them. The brand presents the supplement as a consolidated alternative for owners who would otherwise buy multiple targeted products.

“I created Buddy because I wanted to go beyond advice—I want to offer a real solution to the health challenges faced by our dogs,” Guy said in the release. “Many dog parents feel overwhelmed by today’s pet supplements. I’m proud to cut through the noise with a 10-in-1 product that’s simple, effective, and grounded in science.” Company materials also name Rudder, an animal included in the brand’s launch creative, and note the founder’s existing audience: the announcement lists approximately 670,000 people connected to Guy’s social channels.

The launch situates Buddy in a crowded and rapidly evolving market. Over the past decade the pet supplement market has expanded from a niche segment into a multibillion‑dollar global industry, with estimates placing the market at roughly $2.4–3.0 billion in 2023–2024 and forecasts projecting mid‑single‑digit annual growth into the early 2030s. The company framed Buddy as a single, science-forward choice within that broader market.

Premium dog supplements commonly include ingredients such as omega-3 fatty acids (for anti-inflammatory support and skin and coat health), glucosamine and chondroitin (targeted for joint health and osteoarthritis support), antioxidants like vitamins C and E (for immune and cellular health), and probiotics (for digestive balance). Company statements emphasize Buddy’s use of natural, active ingredients, aligning the product with those category norms while keeping the full ingredient list behind its product materials.

Industry observers and the launch materials alike emphasized convenience as a selling point: Buddy is presented as a meal-time topper intended for daily use, aiming to simplify routines for owners juggling multiple supplements. The release emphasizes scientific grounding in formulation, though it stops short of detailing specific clinical trials or third-party testing in the announcement.

As part of the wider context for consumers, the company’s release echoed a common industry caveat: dog owners should choose supplements when they address a specific, veterinarian‑recommended need. Dogs eating a complete and balanced AAFCO‑compliant diet typically do not require extra vitamins or minerals, and excesses can be harmful, the materials noted—an acknowledgment reflecting ongoing conversations in veterinary and consumer circles about responsible supplement use.

The immediate next steps outlined in the release focused on availability and consumer adoption. While the announcement did not specify retail partners or pricing, it positioned Buddy as a mainstream consumer product intended to be integrated into daily feeding routines. The company said it would prioritize consumer education and adoption as the brand rolls out its first product to the market it described as highly competitive but receptive to consolidated, science-oriented solutions.

Launched publicly on December 19, 2024, in New York, Buddy represents Maddie Guy’s first formal product entry into the pet wellness marketplace. The announcement signals the brand’s intent to leverage Guy’s built audience and to stake a claim in the growing supplement category by offering a single, multi-benefit option for dog owners seeking a streamlined approach to canine health.

Source

Original reporting: view the original article and company materials distributed on Business Wire.

Comments are closed.